Skip to content

A Clinical Study for Pain Analgesia with Transversus Abdominis Plane technique after Cesarean Section

A Clinical Study for Pain Analgesia with Transversus Abdominis Plane technique after Cesarean Section

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022502
Enrollment
Unknown
Registered
2019-04-14
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after Cesarean Section

Interventions

Patient Controlled Analgesia(PCA):PCA with butorphanol
PCA+TAP:PCA with butorphanol + TAP with ropivacaine

Sponsors

Women' Hosipital of Nanjing Medical University(Nanjing Maternity and Child Health Care Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: ASA I or ASA II; Aged 20-45 years; Weight 60-80 kg; Height 152-175 cm; Gestational aged 37-42 weeks; Scar uterus (Transverse incision); Patients who require TAP analgesia.

Exclusion criteria

Exclusion criteria: Severe thrombocytopenia; Abnormal coagulation function; Severe spinal deformity and other intraspinal anesthesia contraindications; Unable to understand the VAS of pain or to cooperate with the test; Poor anesthetic effect during the operation; Requiring intravenous adjuvant administration; Known research drug endowment or other drug allergies in this study; BMI > 30 kg/m2;Infection of TAP puncture site; Unable to implement TAP; Sedative, Hypnotic, Analgesic drugs before operation; History of neurological and psychiatric diseases; Severe heart, lung, liver, kidney dysfunction, etc.

Design outcomes

Primary

MeasureTime frame
Analgesic effects;Biochemical indexes: CGRP, SP, PGE2, 5-HT, bradykinin;

Secondary

MeasureTime frame
Consumption of opioids;

Countries

China

Contacts

Public ContactFan Xia

Women' Hosipital of Nanjing Medical University (Nanjing Maternity and Child Health Care Hospital)

xiafan54@163.com+86 13770616851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026